Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Explore value oriented index funds retirement to identify cost-effective options and build a sustainable retirement portfolio. This intro covers why low fees matter and how to start aligning funds with long-term goals.
23,917 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
AARP launches its largest Community Challenge round yet, awarding $8.3 million to fund 750 projects that upgrade hous...
When a top executive sells a large block of stock, investors often wonder about the meaning behind the move. This gui...
Retail buyers are chasing physical card collectibles tied to crypto platforms, signaling a shift from traditional Tre...
Insider sales spark questions about a stock's health. Here's a practical, data-backed guide to interpret a VP selling...
SpaceX grabs headlines, yet smart investors look for real performance. Meet two growth stocks I prefer over the hype:...
A mid-year luxury market report shows AI-generated fortunes fueling a luxury buyers shift wealth, driving demand for ...
Oracle reports a powerful cloud quarter and record backlog, signaling a potential future milestone. Yet mounting capi...
Broadcom quietly dominating chips is reshaping the AI hardware market. Here are five overlooked US stocks delivering ...
Two veteran reporters clash over OpenAI’s potential IPO. One sees missteps and scope creep; the other argues leaks dr...
As Japan faces a shrinking workforce and aging digital infrastructure, devin-kun is emerging as a pivotal tool to mod...
Vitalik Buterin unveiled a three- to four-year Lean Ethereum upgrade, placing ETH’s institutional appeal on a four-ye...